Drugs / flurbiprofen axetil
Trials 15 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04611763 | Sep 2021 → Oct 2023 | — | Beijing Friendship Hospital | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05504265 | Oct 2022 → Sep 2025 overdue | esophageal cancer | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Recruiting | No outcome recorded |
| Phase 45 trials | ||||||
| Phase 4 | NCT07315022 | Aug 2024 → Aug 2025 | — | First Affiliated Hospital, Sun Yat-Sen University | Completed | No outcome recorded |
| Phase 4 | NCT03200600 | Aug 2017 → Dec 2018 | delirium, non-small cell lung carcinoma | Peking University First Hospital | Terminated | No outcome recorded |
| Phase 4 | NCT03172988 | Aug 2017 → Dec 2018 | non-small cell lung carcinoma | Peking University First Hospital | Terminated | No outcome recorded |
| Phase 4 | NCT02094339 | Mar 2014 → Jun 2016 | — | Guangzhou General Hospital of Guangzhou Military Command | Unknown | No outcome recorded |
| Phase 4 | NCT00725218 | May → Aug 2008 | — | Nanjing Medical University | Completed | No outcome recorded |
| Phase not applicable8 trials | ||||||
| — | NCT07209345 | Oct 2025 → Oct 2026 expected | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07149545 | Oct 2025 → Jan 2026 | atrial fibrillation | Beijing Anzhen Hospital | Completed | No outcome recorded |
| — | NCT06015165 | Sep 2024 → Jun 2025 overdue | — | China-Japan Friendship Hospital | Recruiting | No outcome recorded |
| — | NCT05624359 | Nov 2023 → Mar 2026 | — | Beijing Tiantan Hospital | Suspended | No outcome recorded |
| — | NCT04627779 | Jan → Oct 2021 | — | Beijing Friendship Hospital | Unknown | No outcome recorded |
| — | NCT03562611 | Jun → Sep 2018 | — | Sun Yat-sen University | Completed | No outcome recorded |
| — | NCT04048070 | May → Oct 2018 | chronic rhinosinusitis | Beijing Tongren Hospital | Completed | No outcome recorded |
| — | NCT02595333 | Nov 2015 → Aug 2017 | — | Fudan University | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 8 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT05229913 Background | Feb → Sep 2022 | postpartum depression | Qinghai University | Unknown | No outcome recorded |
| Phase 4 | NCT03147066 Comparator | Sep → Oct 2017 | interstitial cystitis | Jianjun Yang | Completed | No outcome recorded |
| Phase 4 | NCT01872494 Comparator | May 2013 → Feb 2014 | — | Guangzhou General Hospital of Guangzhou Military Command | Completed | No outcome recorded |
| Phase not applicable5 trials | ||||||
| — | NCT05577962 Background | Feb → Sep 2023 | — | Beijing Friendship Hospital | Unknown | No outcome recorded |
| — | NCT03422887 Comparator | Jan → Aug 2018 | — | Sun Yat-sen University | Completed | No outcome recorded |
| — | NCT03823846 Comparator | Nov 2017 → Aug 2020 | anaplastic cancer, neuropathy, painful | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
| — | NCT02604797 Background | Jan 2016 → Jan 2017 | — | Fudan University | Unknown | No outcome recorded |
| — | NCT02043366 Comparator | Feb 2014 → Jun 2015 | — | Tianjin Medical University General Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 23 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flurbiprofen axetil | “Flurbiprofen axetil (FA), as an injectable nonselective cyclooxygenase inhibitor, is a widely prescribed NSAID for postoperative pain.” NCT05624359 ↗22“Postoperative intravenous analgesia pump formula：Esketamine 0.2mg/kg + Sufentanil 1ug/kg+ Flurbiprofen Axetil 200mg.” NCT05229913 ↗ “NSAIDs such as flurbiprofen axetil or ibuprofen will be administered as a complementary treatment option.” NCT06015165 ↗ “primary cesarean section+postoperative analgesia with sufentanil plus flurbiprofen axetil group” NCT02595333 ↗ “flurbiprofen axetil 250mg,palonosetron 0.5mg,pentazocine 240mg.dezocine 30mg” NCT02094339 ↗ “Flurbiprofen axetil (FA) is an injectable NSAID for postoperative analgesia” NCT07209345 ↗ “flurbiprofen axetil 50mg for preemptive analgesia” NCT05577962 ↗ |
| Action | Inhibit | “functioning via block the synthesis of prostaglandin E (PGE).” NCT00725218 ↗ |
| Modality | Other / unclassified | “Flurbiprofen Axetil is a target-distributable non-steroidal anti-inflammatory drug (NSAID)” NCT00725218 ↗ |
| Route | Intravenous | “Flurbiprofen axetil is intravenously administrated” NCT02043366 ↗ |